PRESS RELEASE: Patients Rising Releases New Rare Disease Drug Assessment Standards Aimed at Improving Health Equity

Press Contact: Sarah Shelsonsshelson@riesterpublicaffairs.com New framework for the evaluation of rare disease therapies prioritizes patient experiences, feedback, and needs   WASHINGTON — Patients...

Healthcare That is Fit for Service

Veterans Have An Urgent Need for Better HealthcareVeterans are American heroes that deserve the highest level of respect, care and dignity that our nation can offer. Yet, Uncle Sam has fallen short...

ICER’s Latest: A draft evidence report on treatments for vasomotor symptoms of menopause

On October 11, 2022 2021, ICER released a draft evidence report, “Fezolinetant for Moderate to Severe Vasomotor Symptoms Associated with Menopause.”  This is the first step in ICER’s assessment...

 Making effective decisions in health care requires a thorough understanding of the patient perspective, as well as robust, precise measures of response to therapy. The Patient Access & Affordability Project evaluates the various frameworks used to assess and demonstrate the value of new treatments to ensure that the patient is kept at the center of health care decisions.

The Latest Insights

Healthcare That is Fit for Service

Healthcare That is Fit for Service

Veterans Have An Urgent Need for Better HealthcareVeterans are American heroes that deserve the highest level of respect, care and dignity that our nation can offer. Yet, Uncle Sam has fallen short on the promise to have the backs of the men and women who wore the...

read more
ICER’s Latest: Draft Evidence Report on New ALS Treatments

ICER’s Latest: Draft Evidence Report on New ALS Treatments

On June 14, 2022, ICER released its draft evidence report, “AMX0035 and Oral Edaravone for Amyotrophic Lateral Sclerosis.” This is the first step in ICER's review process. A final evidence report is expected to be released in mid-September. Background on ALS...

read more

Get Updates in Your Inbox

Sign Up.  Stay Informed.